RocketDNA Ltd (ASX: RKT) - ETF Exposure

- Current share price for RKT : $0.021

RocketDNA Ltd (RKT) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a multinational drone-based data service and technology provider, listed on the ASX, offering aerial surveying, mapping, security, surveillance, and asset inspection for enterprise customers in the mining, agricultural, and engineering sectors.

RKT General Information ⁺

ASX Code	RKT
Website	http://www.rocketdna.com
Industry/Sector	Electronic Equipment & Instruments
Market Cap ($M)	28
RKT Share Price	$0.021
Day High	$0.021
Day Low	$0.021
Last Close	$0.021
RKT Share Price Movement	- ( No change )

Prices as at 11:05, 30 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to RKT

RocketDNA Ltd (RKT) is held across 3 ETFs spanning strategies that include electronic equipment & instruments exposure . Its weighting in those funds means performance can have an outsized influence - when RKT moves, funds like MQYM, MQIO and MQDB that hold it can move with it.

For more concentrated exposure, ETFs such as MQYM (Macquarie Global Yield Maximiser Active ETF) allocate about 0.4% to RKT , while the average exposure across all 3 ETFs that hold it is around 0.2% .

Top ETF holdings

Macquarie Global Yield Maximiser Active ETF (MQYM) ~ 0.4%
Macquarie Income Opp Active ETF (Managed Fund) (MQIO) ~ 0%
Macquarie Dynamic Bond Active ETF (Managed Fund) (MQDB) ~ 0%

Last updated: ETF data and holdings as at 29 October 2026

Own RKT directly or through an ETF?

How does holding RocketDNA Ltd (RKT) shares directly compare to ETFs that include it?

	RKT Direct	MQYM ASX	MQIO ASX	MQDB ASX
Holdings	1 company	76 holdings	370 holdings	256 holdings
RKT Weight	100%	0.4%	0%	0%
Diversification	Single Stock	Broad	Broad	Broad
Annual Cost	Brokerage only	0.59% p.a.	0.49% p.a.	0.61% p.a.
Approx. Yield	-	7.33%	4.95%	3.72%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not RKT's direct yield. Annual cost uses each ETF's MER.

RKT Exposure on $10,000 investment

How a $10,000 investment in RocketDNA Ltd (RKT) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
RocketDNA Ltd (RKT)	Direct share	$0.021	-8.70%	-$870	$9,130
Macquarie Global Yield Maximiser Active ETF (MQYM)	Fixed Income - Global	$48.790	0.41%	+$41	$10,041
Macquarie Income Opp Active ETF (Managed Fund) (MQIO)	Fixed Income - Global	$10.620	0.28%	+$28	$10,028
Macquarie Dynamic Bond Active ETF (Managed Fund) (MQDB)	Fixed Income - Global	$10.470	0.67%	+$67	$10,067

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

RocketDNA Ltd (RKT) ETFs

3 ETFs hold RocketDNA Ltd (RKT).

ETF	RKT Weight	MER	Yield
Macquarie Global Yield Maximiser Active ETF (MQYM)	0.4%	0.59%	7.33%
Macquarie Income Opp Active ETF (Managed Fund) (MQIO)	0%	0.49%	4.95%
Macquarie Dynamic Bond Active ETF (Managed Fund) (MQDB)	0%	0.61%	3.72%

RocketDNA Ltd (RKT) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from RocketDNA Ltd (RKT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

RocketDNA Ltd (RKT) price-sensitive announcements

RKT - RocketDNA September 2026 Quarterly Report & Appendix 4C

RocketDNA Ltd’s September 2026 Quarterly Activities Report and Appendix 4C show the compan

RocketDNA Ltd (RKT)
29 Oct 2026 | 8:37 AM

RKT - RocketDNA Completes $2.23m Strategic Placement

RocketDNA Ltd announced on 8 October 2026 that it had successfully completed a strategic p

RocketDNA Ltd (RKT)
8 Oct 2026 | 9:46 AM

RKT - Trading Halt

On 7 October 2026, ASX announced that trading in RocketDNA Ltd (ASX: RKT) securities had b

RocketDNA Ltd (RKT)
7 Oct 2026 | 9:15 AM

RKT - Appendix 4D and Half Year Financial Report

The half-year financial report for RocketDNA Ltd as of 30 June 2026 presents a consolidate

RocketDNA Ltd (RKT)
19 Aug 2026 | 7:56 AM

RocketDNA Ltd (RKT) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	RocketDNA September 2026 Quarterly Report & Appendix 4C	29 Oct 2026 8:37AM	$0.023	$0.021	fallen by 8.70%
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	Notification regarding unquoted securities - RKT	22 Oct 2026 8:54AM	$0.023	$0.021	fallen by 8.70%
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	Proposed issue of securities - RKT	21 Oct 2026 9:36AM	$0.024	$0.021	fallen by 12.50%
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	RocketDNA Appoints Chris Crosby to Advisory Board	21 Oct 2026 9:30AM	$0.024	$0.021	fallen by 12.50%
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	Change in substantial holding - Sadietilly Capital	14 Oct 2026 8:37AM	$0.022	$0.021	fallen by 4.55%
RocketDNA Ltd (RKT) ORDINARY FULLY PAID	Information Technology	$28	Cleansing Notice	13 Oct 2026 8:48AM	$0.022	$0.021	fallen by 4.55%

RKT Financial Summary

Year to Dec	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$2.76	-$0.30	7.10%	0.00%	0.0%
2024A	-$1.93	-$0.30	-6.70%	0.00%	0.0%
2023A	-$1.66	-$0.30	-34.80%	0.00%	0.0%

RKT Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
Codan Limited (CDA)	$10,779M	0.6884	0.7034	0.0842	61.6475	36.1900	33.3785	0.82%	1.21%	1.30%
Elsight Limited (ELS)	$637M	-2.2233	0.6667	0.6071	55.9524	33.5714	20.8889	0.00%	0.00%	0.00%
RocketDNA Ltd (RKT)	$31M	0.0714	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%

RKT Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	3.13	0.00
Market	0.30	13.20	1.03	0.74
Sector	1.42	33.20	1.15	0.92

RKT Directors

Name	Position	Start Date
Dr Christopher Clark	Chief Executive Officer, Executive Director	3 Dec 2020
Mr Paul Williamson	Chief Financial Officer, Executive Director	22 Jun 2022
Mr David Morton	Non-Executive Director, Non-Executive Chairman	28 Mar 2023

RocketDNA Ltd (RKT) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
29 May 2026	WILLIAMSON, Paul	Issued	Related Securities	10,000,000	$0.019	$190,000.000
29 May 2026	CLARK, Christopher	Issued	Related Securities	20,000,000	$0.019	$380,000.000
24 Dec 2025	CLARK, Christopher	Issued	Indirect Shares	666,666	$0.015	$10,000.000

See all changes in directors' interest & trades for RocketDNA Ltd (RKT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

RKT Management

Name	Position
Stephen Buckley	Company Secretary

RKT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in RocketDNA Ltd (RKT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
160,443,566 (14.11%)	Daniel Narayan

RKT Calendar of Events

Date	Event
18 August 2027	Report (Interim)
24 February 2027	Report (Annual)
24 February 2027	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us